Company Analysis Procter & Gamble Health Limited
1. Summary
Advantages
- The company's current efficiency (ROE=37.34%) is higher than the sector average (ROE=10.54%)
Disadvantages
- Price (5399 βΉ) is higher than fair price (1334.05 βΉ)
- Dividends (3.92%) are below the sector average (9.04%).
- The stock's return over the last year (14.84%) is lower than the sector average (17.06%).
- Current debt level 1.51% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Procter & Gamble Health Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 4.6% | 1.8% | 1.3% |
| 90 days | 3.2% | 0% | 11.2% |
| 1 year | 14.8% | 17.1% | 7.4% |
PGHL vs Sector: Procter & Gamble Health Limited has slightly underperformed the "Healthcare" sector by -2.22% over the past year.
PGHL vs Market: Procter & Gamble Health Limited has outperformed the market by 7.41% over the past year.
Stable price: PGHL is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: PGHL with weekly volatility of 0.2854% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (5399 βΉ) is higher than the fair price (1334.05 βΉ).
Price is higher than fair: The current price (5399 βΉ) is 75.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (40.9) is lower than that of the sector as a whole (59.66).
P/E vs Market: The company's P/E (40.9) is lower than that of the market as a whole (65.28).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (15.27) is higher than that of the sector as a whole (6.61).
P/BV vs Market: The company's P/BV (15.27) is higher than that of the market as a whole (6.43).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (7.14) is lower than that of the sector as a whole (9.33).
P/S vs Market: The company's P/S indicator (7.14) is lower than that of the market as a whole (18.87).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (18.47) is lower than that of the sector as a whole (141.68).
EV/Ebitda vs Market: The company's EV/Ebitda (18.47) is lower than that of the market as a whole (24.54).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -0.4132% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-0.4132%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-3.49%).
5.4. ROE
ROE vs Sector: The company's ROE (37.34%) is higher than that of the sector as a whole (10.54%).
ROE vs Market: The company's ROE (37.34%) is higher than that of the market as a whole (3.54%).
5.5. ROA
ROA vs Sector: The company's ROA (25.3%) is higher than that of the sector as a whole (7.51%).
ROA vs Market: The company's ROA (25.3%) is higher than that of the market as a whole (7.88%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.95%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (15.48%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 3.92% is below the average for the sector '9.04%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.92% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 3.92% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (206.48%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
